WOOJUNG BIO, Inc. (KOSDAQ:215380)
South Korea · Delayed Price · Currency is KRW 2,450.00
-255.00 (-9.43%)
At close: Apr 2, 2026
WOOJUNG BIO Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -5,547 | 225.3 | -5,054 | -1,880 | -1,926 |
Depreciation & Amortization | 3,772 | 4,202 | 4,323 | 4,247 | 2,701 |
Loss (Gain) From Sale of Assets | -181.47 | 48.6 | -27.2 | 61.77 | 53.59 |
Asset Writedown & Restructuring Costs | 693.21 | -560.38 | - | - | - |
Loss (Gain) From Sale of Investments | 130.06 | 50.13 | -5.51 | 875.87 | -1,182 |
Loss (Gain) on Equity Investments | 2.31 | 3 | - | - | - |
Provision & Write-off of Bad Debts | 163.82 | -283.78 | -483.71 | -188.85 | -278.63 |
Other Operating Activities | -170.26 | -1,688 | 436.36 | -1,261 | -401.15 |
Change in Accounts Receivable | 1,647 | 956.46 | -4,442 | 3,499 | -732.74 |
Change in Inventory | -2,844 | 38.75 | -424.43 | 1,177 | -474.57 |
Change in Accounts Payable | 458.96 | 1,952 | -269.69 | -148.15 | 349.66 |
Change in Income Taxes | - | - | - | -11.68 | -22.01 |
Change in Other Net Operating Assets | 1,245 | -6,070 | 2,725 | -3,869 | 3,640 |
Operating Cash Flow | -630.5 | -1,126 | -3,222 | 2,502 | 1,728 |
Operating Cash Flow Growth | - | - | - | 44.82% | - |
Capital Expenditures | -253.96 | -292.45 | -842.88 | -11,422 | -36,684 |
Sale of Property, Plant & Equipment | 219.29 | 101.52 | 80.64 | 344.56 | 72.77 |
Sale (Purchase) of Intangibles | -5.33 | -17.06 | -51.36 | -87.97 | 54.36 |
Investment in Securities | 679.13 | -882.87 | 880.31 | 4,830 | 6,891 |
Other Investing Activities | 1,541 | 43.18 | 69.16 | -345.79 | 228.64 |
Investing Cash Flow | 2,182 | -1,048 | 135.86 | -6,681 | -29,437 |
Short-Term Debt Issued | 2,271 | 2,439 | 12,700 | 8,581 | 3,700 |
Long-Term Debt Issued | 1,000 | 30,000 | 14,313 | - | 24,000 |
Total Debt Issued | 3,271 | 32,439 | 27,013 | 8,581 | 27,700 |
Short-Term Debt Repaid | -3,000 | -10,357 | -5,830 | -10,099 | -2,785 |
Long-Term Debt Repaid | -1,905 | -23,534 | -16,285 | -545.31 | -1,032 |
Total Debt Repaid | -4,906 | -33,892 | -22,115 | -10,645 | -3,817 |
Net Debt Issued (Repaid) | -1,634 | -1,453 | 4,898 | -2,064 | 23,883 |
Issuance of Common Stock | - | 2,043 | - | - | - |
Other Financing Activities | -103.02 | 186.05 | 27.36 | 148.55 | 172.78 |
Financing Cash Flow | -1,737 | 775.92 | 4,925 | 7,302 | 24,056 |
Foreign Exchange Rate Adjustments | - | 1.11 | 0.66 | -1.36 | -0.44 |
Net Cash Flow | -185.69 | -1,397 | 1,840 | 3,122 | -3,653 |
Free Cash Flow | -884.46 | -1,419 | -4,065 | -8,919 | -34,956 |
Free Cash Flow Margin | -2.35% | -3.28% | -10.53% | -19.01% | -111.90% |
Free Cash Flow Per Share | -53.10 | -94.47 | -258.57 | -692.61 | -2922.44 |
Cash Interest Paid | 2,172 | 2,562 | 2,347 | 1,217 | 813.03 |
Cash Income Tax Paid | 7.67 | -3.69 | -5.93 | -7.35 | -7.21 |
Levered Free Cash Flow | 1,217 | -7,219 | -8,994 | -5,372 | -24,716 |
Unlevered Free Cash Flow | 3,025 | -5,202 | -6,979 | -3,624 | -24,311 |
Change in Working Capital | 506.73 | -3,123 | -2,411 | 647.41 | 2,760 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.